Previous Article | Next Article 
Molecular and Cellular Biology, June 2004, p. 5223-5234, Vol. 24, No. 12
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.12.5223-5234.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Epstein-Barr Virus Latent Membrane Protein 1 Induces Synthesis of Hypoxia-Inducible Factor 1
Naohiro Wakisaka,1,2 Satoru Kondo,1,2 Tomokazu Yoshizaki,2 Shigeyuki Murono,2 Mitsuru Furukawa,2 and Joseph S. Pagano1*
Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599-7295,1
Department of Otolaryngology, School of Medicine, Kanazawa University, Kanazawa 920-8640, Japan2
Received 16 October 2003/
Returned for modification 5 December 2003/
Accepted 25 March 2004
Hypoxia-inducible factor 1 (HIF-1) is a heterodimeric basic helix-loop-helix transcription factor composed of HIF-1
and HIF-1ß that is the central regulator of responses to hypoxia. The specific binding of HIF-1 to the hypoxia-responsive element (HRE) induces the transcription of genes that respond to hypoxic conditions, including vascular endothelial growth factor (VEGF). Here we report that expression of HIF-1
is increased in diverse Epstein-Barr virus (EBV)-infected type II and III cell lines, which express EBV latent membrane protein 1 (LMP1), the principal EBV oncoprotein, as well as other latency proteins, but not in the parental EBV-negative cell lines. We show first that transfection of an LMP1 expression plasmid into Ad-AH cells, an EBV-negative nasopharyngeal epithelial cell line, induces synthesis of HIF-1
protein without increasing its stability or mRNA level. The mitogen-activated protein kinase (MAPK) kinase inhibitor PD98059 markedly reduces induction of HIF-1
by LMP1. Catalase, an H2O2 scavenger, strongly suppresses LMP1-induced production of H2O2, which results in a decrease in the expression of HIF-1
induced by LMP1. Inhibition of the NF-
B, c-jun N-terminal kinase, p38 MAPK, and phosphatidylinositol 3-kinase pathways did not affect HIF-1
expression. Moreover, LMP1 induces HIF-1 DNA binding activity and upregulates HRE and VEGF promoter transcriptional activity. Finally, LMP1 increases the appearance of VEGF protein in extracellular fluids; induction of VEGF is suppressed by PD98059 or catalase. These results suggest that LMP1 increases HIF-1 activity through induction of HIF-1
protein expression, which is controlled by p42/p44 MAPK activity and H2O2. The ability of EBV, and specifically its major oncoprotein, LMP1, to induce HIF-1
along with other invasiveness and angiogenic factors reported previously discloses additional oncogenic properties of this tumor virus.
* Corresponding author. Mailing address: Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599-7295. Phone: (919) 966-8644. Fax: (919) 966-9673. E-mail:
Joseph_Pagano{at}med.unc.edu.
Molecular and Cellular Biology, June 2004, p. 5223-5234, Vol. 24, No. 12
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.12.5223-5234.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
O'Neil, J. D., Owen, T. J., Wood, V. H. J., Date, K. L., Valentine, R., Chukwuma, M. B., Arrand, J. R., Dawson, C. W., Young, L. S.
(2008). Epstein-Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro. J. Gen. Virol.
89: 2833-2842
[Abstract]
[Full Text]
-
Tsuji, A., Wakisaka, N., Kondo, S., Murono, S., Furukawa, M., Yoshizaki, T.
(2008). Induction of Receptor for Advanced Glycation End Products by EBV Latent Membrane Protein 1 and Its Correlation with Angiogenesis and Cervical Lymph Node Metastasis in Nasopharyngeal Carcinoma. Clin. Cancer Res.
14: 5368-5375
[Abstract]
[Full Text]
-
Gerber, S. A., Pober, J. S.
(2008). IFN-{alpha} Induces Transcription of Hypoxia-Inducible Factor-1{alpha} to Inhibit Proliferation of Human Endothelial Cells. J. Immunol.
181: 1052-1062
[Abstract]
[Full Text]
-
Bayele, H. K., Peyssonnaux, C., Giatromanolaki, A., Arrais-Silva, W. W., Mohamed, H. S., Collins, H., Giorgio, S., Koukourakis, M., Johnson, R. S., Blackwell, J. M., Nizet, V., Srai, S. K. S.
(2007). HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite. Blood
110: 3039-3048
[Abstract]
[Full Text]
-
Charalambous, C. T., Hannigan, A., Tsimbouri, P., McPhee, G. M., Wilson, J. B.
(2007). Latent membrane protein 1-induced EGFR signalling is negatively regulated by TGF{alpha} prior to neoplasia. Carcinogenesis
28: 1839-1848
[Abstract]
[Full Text]
-
Horikawa, T., Yang, J., Kondo, S., Yoshizaki, T., Joab, I., Furukawa, M., Pagano, J. S.
(2007). Twist and Epithelial-Mesenchymal Transition Are Induced by the EBV Oncoprotein Latent Membrane Protein 1 and Are Associated with Metastatic Nasopharyngeal Carcinoma. Cancer Res.
67: 1970-1978
[Abstract]
[Full Text]
-
Kondo, S., Yoshizaki, T., Wakisaka, N., Horikawa, T., Murono, S., Jang, K. L., Joab, I., Furukawa, M., Pagano, J. S.
(2007). MUC1 Induced by Epstein-Barr Virus Latent Membrane Protein 1 Causes Dissociation of the Cell-Matrix Interaction and Cellular Invasiveness via STAT Signaling. J. Virol.
81: 1554-1562
[Abstract]
[Full Text]
-
Hwang, I. I. L., Watson, I. R., Der, S. D., Ohh, M.
(2006). Loss of VHL Confers Hypoxia-Inducible Factor (HIF)-Dependent Resistance to Vesicular Stomatitis Virus: Role of HIF in Antiviral Response. J. Virol.
80: 10712-10723
[Abstract]
[Full Text]
-
Kondo, S., Seo, S. Y., Yoshizaki, T., Wakisaka, N., Furukawa, M., Joab, I., Jang, K. L., Pagano, J. S.
(2006). EBV Latent Membrane Protein 1 Up-regulates Hypoxia-Inducible Factor 1{alpha} through Siah1-Mediated Down-regulation of Prolyl Hydroxylases 1 and 3 in Nasopharyngeal Epithelial Cells.. Cancer Res.
66: 9870-9877
[Abstract]
[Full Text]
-
Cai, Q., Lan, K., Verma, S. C., Si, H., Lin, D., Robertson, E. S.
(2006). Kaposi's Sarcoma-Associated Herpesvirus Latent Protein LANA Interacts with HIF-1{alpha} To Upregulate RTA Expression during Hypoxia: Latency Control under Low Oxygen Conditions.. J. Virol.
80: 7965-7975
[Abstract]
[Full Text]
-
Zhao, L.-J., Zhang, X.-L., Zhao, P., Cao, J., Cao, M.-M., Zhu, S.-Y., Liu, H.-Q., Qi, Z.-T.
(2006). Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line. J. Leukoc. Biol.
80: 424-432
[Abstract]
[Full Text]
-
Wenger, R. H., Stiehl, D. P., Camenisch, G.
(2005). Integration of Oxygen Signaling at the Consensus HRE. Sci Signal
2005: re12-re12
[Abstract]
[Full Text]
-
Ning, S., Huye, L. E., Pagano, J. S.
(2005). Interferon Regulatory Factor 5 Represses Expression of the Epstein-Barr Virus Oncoprotein LMP1: Braking of the IRF7/LMP1 Regulatory Circuit. J. Virol.
79: 11671-11676
[Abstract]
[Full Text]
-
Zhang, L., Zhang, J., Lambert, Q., Der, C. J., Del Valle, L., Miklossy, J., Khalili, K., Zhou, Y., Pagano, J. S.
(2004). Interferon Regulatory Factor 7 Is Associated with Epstein-Barr Virus-Transformed Central Nervous System Lymphoma and Has Oncogenic Properties. J. Virol.
78: 12987-12995
[Abstract]
[Full Text]
-
Carbone, M., Klein, G., Gruber, J., Wong, M.
(2004). Modern Criteria to Establish Human Cancer Etiology. Cancer Res.
64: 5518-5524
[Abstract]
[Full Text]